Background and Purpose Polymorphonuclear leukocytes have been implicated in the development of the "no-reflow" phenomenon after focal cerebral ischemia and reperfusion. To further understand the role of granulocytes in microvascular occlusions, the responses of the granulocyte-endothelial cell adhesion molecules P-selectin and intercellular adhesion molecule-1 during middle cerebral artery ischemia and reperfusion were examined in a primate model.
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Background and Purpose Polymorphonuclear leukocytes have been implicated in the development of the "no-reflow" phenomenon after focal cerebral ischemia and reperfusion. To further understand the role of granulocytes in microvascular occlusions, the responses of the granulocyte-endothelial cell adhesion molecules P-selectin and intercellular adhesion molecule-1 during middle cerebral artery ischemia and reperfusion were examined in a primate model.
Methods Twelve adolescent male baboons were used for 2-hour middle cerebral artery occlusion (n=3) or for 3-hour occlusion with 1-hour (n=3), 4-hour (n=3), and 24-hour (n=3) reperfusion, and three separate unoperated primates served as controls. A quantitative immunohistochemical study of the microvascular distribution of P-selectin and intercellular adhesion molecule-1 was performed using 10-/j.m frozen sections from basal ganglia analyzed with computerized light microscopy video imaging.
Results Significant (P<.05) persistent upregulation of P-selectin (beginning during ischemia) and transient upregulation of intercellular adhesion molecule-1 (at 1 and 4 hours of reperfusion) were observed on endothelium of selected postcapillary microvessels of the ischemic lenticulostriate artery territory. Platelet accumulation also occurred in this territory and was responsible for a significant proportion of the nonendothelial P-selectin signal at 24 hours after reperfusion.
Conclusions Focal cerebral ischemia/reperfusion stimulates endothelial P-selectin and intercellular adhesion molecule-1 expression in brain microvessels in the ischemic zone, which may contribute to enhanced leukocyte adherence and persistent activation. may contribute to postreperfusion reflow abnormalities in the microvasculature. However, little is known about how the affected microvascular endothelia respond during focal cerebral ischemia and reperfusion. The glycoprotein P-selectin (GMP-140, PADGEM, CD62) is an adhesion molecule expressed on stimulated endothelial cells and platelets, which mediates the interaction of these cells with PMN leukocytes and monocytes. 56 In inflammation and thrombosis, P-selectin has recently been shown to mediate the interaction of granulocytes with platelets and with stimulated endothelium in the region of tissue injury, 56 to underlie It may be a receptor responsible for granulocyte "rolling" on endothelium. 8 P-selectin is located in WeibelPalade bodies of endothelial cells 910 and the a-granules 11 ' 12 or dense granules 13 of platelets. A primary interaction between the granulocyte and the stimulated endothelial cell also occurs through the binding of the adhesive integrin complex CD11/CD18 of the PMN leukocyte to the endothelial intercellular adhesion molecule-1 (ICAM-1).
14 ICAM-1 is an inducible endothelial cell ligand expressed on the cell surface after exposure to cytokines such as tissue necrosis factor-a (TNF-a), interleukin-1 (IL-1), and lipopolysaccharide (LPS). 15 ICAM-1 is an important receptor for granulocyte adhesion 16 that also mediates transmigration. 17 The relative endothelial cell expression of the P-selectin, E-selectin, and ICAM-1 mediator complexes in vitro has been recently reviewed. 18 -19 In the present study, we examined the vascular expression of P-selectin and ICAM-1 in the lenticulostriatal artery (LSA) territory during focal cerebral ischemia and reperfusion by MCA occlusion/reperfusion with immunohistochemical techniques using well-characterized anti-human polyclonal or monoclonal antibodies (MoAbs) in the awake baboon model. These studies confirm the upregulation of both adhesion receptors in the LSA microvasculature, which comple-merits the previous finding of PMN leukocytes in this territory.
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Materials and Methods
Twelve adolescent male baboons (Papio anubislcynocephalus) weighing 8.7 to 11.4 kg were used for the MCA occlusion/ reperfusion studies, and three separate primates weighing 9.2 to 25.0 kg served as controls. Before entry into this study, all animals lacked evidence of disease during a mandated standard quarantine period. The procedures used throughout this study were approved by the Institutional Animal Research Committee and were performed in accordance with standards published by the National Research Council {The Guide for the Care and Use of Laboratory Animals), the National Institutes of Health Policy on Humane Care and Use of Laboratory Animals, and the US Department of Agriculture Animal Welfare Act. In compliance with these standards, every effort was made to ensure that the subjects were free of pain or discomfort. The principal investigator, veterinarian, and primate handling staff were present for all procedures.
Preparation of the non-human primate model of right MCA occlusion and reperfusion by surgical implantation of the MCA occlusion device (PS Medical, Goleta, Calif) has been described in detail elsewhere. 1220 Halothane anesthesia administered as 3% to 5% induction followed by 1.5% to 2.0% maintenance was routine during the surgical procedures. Following surgical recovery, all animals were allowed a 7-day interval before entry into the experimental protocol. All animals entered into the study were clinically free of infection or apparent inflammation and had normal neurological function (score, 100). 21 In this study, 3 animals underwent right MCA occlusion for 2 hours; 9 animals (3 each) underwent MCA occlusion for 3 hours and subsequent reperfusion for 1 hour, 4 hours, or 24 hours; and 3 animals did not undergo the surgical implantation procedure and served as a control group. The experimental paradigm previously reported was followed here exactly. 13 Each experiment was terminated by pressure perfusion with isosmotic perfusion flush solution during reperfusion. 3 Pressure perfusion at the end of 2 hours of MCA occlusion only required simultaneous deflation of the balloon.
Before termination, each animal underwent craniotomy under pentothal sodium (15 mg/kg infusion) anesthesia and mechanical ventilation. 3 A left occipital quadrant cranial window was extended caudally to the foramen magnum and rostrally by segmental removal. Hemorrhage was minimal (10 to 20 mL). Perfusion of the superior thoracic and cranial structures was achieved by infusion of chilled (4°C) perfusion fluid at 180 to 210 mm Hg for 4 minutes (700 to 800 mL/min flow) via left ventricular puncture with simultaneous clamping of the aorta and inferior vena cava, and venting of the right atrium. The perfusion flush solution consisted of 50 g/L bovine serum albumin (Sigma Chemical Co, St Louis, Mo), 2000 IU/L heparin, and 6.7 /i.mol/L sodium nitroprusside (Fisher Scientific, Fair Lawn, NJ) in Plasmalyte (Baxter Healthcare, Deerfield, 111) adjusted to 340 mOsm/L with NaCl, pH 7.4, to wash out all blood elements under antithrombotic conditions. The brain was immediately excised en bloc from the cranium and was immersed in ice. It was subdivided into 1-cm coronal slices immediately, and tissue blocks (1.0x1.0x0.2 to 0.5 cm) from stereoanatomically identical sites of the left and right basal ganglia and temporal cortex were embedded in Tissue-Tek OCT compound (Miles, Inc, Elkhart, Ind) in individual 20x25-mm cryomolds, frozen in 2-methylbutane/dry ice, and stored at -70°C until sectioning.
Well-characterized MoAbs or polyclonal antibodies were used for the immunohistochemical studies. The murine antihuman ICAM-1 MoAb (derived from the clone RR 1/1.1.1 and designated RR 1/1) was the kind gift of R. Rothlein (Boehringer Ingelheim, Ridgefield, Ct). 22 Preliminary experiments demonstrated that ICAM-1 expression in cutaneous microvessels 4 hours after exposure to 10 fig LPS was detectable with RR 1/1 in this species (data not shown). To detect baboon P-selectin, a rabbit polyclonal antibody against human P-selectin, the generous gift of M. Berndt (Baker Medical Research Institute, Prahran, Australia) was used. 23 - 24 This antibody has been shown in our laboratory to specifically bind to a-thrombin-stimulated human and baboon isolated platelets, but not unstimulated platelets, by flow cytometry. It identifies a 140-kD band by Western blot analysis of lysates of purified washed human 23 and baboon platelets (data not shown). The MoAb CLB HEC-75 against the ubiquitous endothelial cell adhesion receptor CD31 was provided by J. van Mourik (Central Laboratorium van de Bloedtransfusiedienst, Amsterdam, the Netherlands) 25 or was obtained commercially (DAKO-CD31, JC/70, DAKO Corp, Carpinteria, Calif). 26 The specific anti-platelet glycoprotein Ilb-IIIa (GPIIb/IHa) antibody, LJ-P^-2 ** was the kind gift of Z. Ruggeri (The Scripps Research Institute, La Jolla, Calif).
Consecutive 10 -/nm cryostat sections from right-to-left matched regions of the post-ischemic/reperfused (right) and normal non-ischemic/reperfused (left) basal ganglia were prepared for immunohistochemistry. 3 Two separate blocks from each region per subject were chosen, to provide six blocks per time point. Consecutive sections from each block were fixed with methanol for 3 minutes at 4°C, immersed in 100 mmol/L glycine in phosphate-buffered saline (PBS) (100 mmol/L Na 2 HPO 4 /NaH 2 PO 4 and 140 mmol/L NaCl adjusted to pH 7.4) for 10 minutes, then rinsed three times with PBS wash solution, and subsequently incubated with Blotto 29 for 30 minutes to reduce nonspecific binding. Fifty microliters of each primary antibody was incubated on each section for 120 minutes, followed by incubation with biotinylated horse anti-mouse or anti-rabbit (P-selectin) immunoglobulin G (1:400 in reagent diluent; Vector Laboratories, Burlingame, Calif) for 30 minutes at 37°C. The sections were sequentially incubated with 0.03% hydrogen peroxide in pure methanol for 20 minutes to block endogenous peroxidase activities, then with streptavidin horseradish peroxidase complex (Vector Laboratories) for 30 minutes. Antibody-bound peroxidase was detected with the chromogen substrate 3-amino-9-ethyl carbazole (AEC Kit, Biomeda Corporation, Foster City, Calif), freshly prepared at 0.02% in 20 mmol/L sodium acetate buffer and 0.03% hydrogen peroxidase, and incubated for 10 minutes. Sections were washed in tap water, counterstained with Mayer's hematoxylin (Biomeda Corporation) for 1 minute, and blued in saturated sodium bicarbonate solution. All immunostained specimens were then mounted with clear mounting medium (Biomeda Corporation). The following immunohistochemical controls were routinely performed on each tissue type: (1) deletion of the primary antibody, (2) deletion of the secondary antibody, and (3) TIB115, a murine MoAb against the irrelevant SV40 large T viral antibody.
To permeabilize the endothelium 30 to assess the intracellular content of endothelial P-selectin, adjacent sections were fixed with acetone and incubated with the anti-P-selectin antibody for 10 minutes.
The absolute number and minimum transverse diameters of manually identified peroxidase-stained microvessels from the basal ganglia of post-ischemic/reperfused and nonischemic territories were determined with the computerized video-imaging system previously described. 1 Minimum transverse diameters of peroxidase-stained vascular structures from non-overlapping images (x400) in a 1000-field matrix (66.4 mm 2 ) were computed from each section with a linear measurement program. Off-line analysis of the microvascular distribution was performed with resident statistical programs.
To determine the exact frequency of P-selectin-and ICAM-1-positive vessels, the number of vessels less than 100 fim in diameter (microvessels) stained by the MoAb CLB-HEC-75 was regarded as the total number of microvessels. respectively. Since P-selectin expression is seen on both stimulated endothelium and platelets, the contribution of platelet (a-granule)-related P-selectin to the overall increase was measured indirectly with the specific anti-platelet GPIIb/IIIa antibody, LJ-P4. The difference in total P-selectin-and GPIIb/ Ilia-positive vessels was regarded as the number of microvessels with endothelium-associated P-selectin expression. The intensity of P-selectin and ICAM-1 peroxidase stain associated with the microvascular endothelia in each section was assessed visually by three observers not aware of the specimen source, timing, or antibody, who graded the stain according to a 3-point scale: 0, no stain; 1, light stain; and 2, strongly stained (Fig 1) . Included in the group with intensity level 1 stain were a small number of microvessels with punctate stain in the vascular lumen adjacent to the endothelium, often at acute bends. Concordance of the intensity judgments with this scale was 97%. The presence of ischemic injury, indicated by the relative degree of neuron damage, was assessed by the method of Eke et al. 31 The center of the ischemic zone was denned as the area with type IV neuronal damage 31 and nonischemic tissue by the presence of type I cells only. Among the post-ischemic/reperfused specimens, 33.6±11.0% of the area analyzed had type IV neuron damage. This area corresponded to variable degrees of visible contiguous tissue disturbance (center of ischemic zone). Tissue peripheral to this injury had some type II and III neuron damage. All values are expressed as literal values (eg, peroxidase stain intensity), as the mean or as the mean±SD. Data from six blocks per time point were analyzed using Student's / test, and statistical significance was set at P<.05. Microvascular diameters were classified in biologically relevant size categories for statistical analysis. 
Results
The appearance of contralateral neurological deficits (hemiparesis and/or unresponsiveness to tactile and visual stimuli) occurred within 10 minutes after MCA occlusion in each subject. A significant and persistent reduction in neurological score to 44.2±13.9 at 1 hour was observed in both the MCA occlusion and MCA occlusion/reperfusion groups. Baseline data of cell blood count (total leukocyte count, 9.2±2.8X10 3 /ML; hematocrit, 35.5±3.6%; platelet count, 432±104xl0 3 / /xL) were not different in each cohort.
The ability of the anti-P-selectin polyclonal antibody and the anti-ICAM-1 MoAb to identify their respective vascular epitopes is indicated in Figs 1 and 2 . The number of microvessels with the endothelial epitope CD31 in both basal ganglia in all subjects was the same as previously reported 3 and did not differ significantly (Table 1). In the control subjects, the fraction of vessels with endothelial surface-expressed P-selectin or ICAM-1 was low (<0.6% and <1.5% of CD31, respectively) ( Tables 2  and 3 ). In the controls, the small number of microvessels with peroxidase stain for each epitope had intensity level 1 only. The remainder of the vessels had no peroxidase stain. Both P-selectin and ICAM-1 were limited to noncapillary microvessels greater than 7.5 fim in diameter (Figs 3 and 4) .
Microvascular endothelial-associated P-selectin (fraction P-selectin/CD31) in sections of the non-ischemic/ reperfused basal ganglia at each time point was not different from the basal ganglia of the control subjects ( Table 2 , Fig 5) . In contrast, microvascular P-selectin expression in the post-ischemic/reperfused basal ganglia was significantly increased (P<.05), mainly in the precapillary and postcapillary vessel range (7.5 to 30.0 /Am) at 2 hours of MCA occlusion ( -1 hour of reperfusion) and at 1 and 24 hours of reperfusion, compared with the control and contralateral basal ganglia. At 2 hours of ischemia (-1 hour of reperfusion) and also at 1 hour of reperfusion, P-selectin was clearly associated with the endothelial lining. During reperfusion, particularly at 4 and 24 hours, an apparent increase in mean fraction P-selectin/CD31 was noted (Fig 5) . Because of the specificity of the anti-P-selectin preparation for activated platelets, the potential contribution of platelets to the P-selectin signal in microvessels of both non-ischemic/reperfused and post-ischemic/reperfused zones was examined. No GPIIb/IIIa-positive vessels were detected in the non-ischemic/reperfused basal ganglia at any time point (Table 2) ; however, the fraction (GPIIb/IIIa)/CD31 increased during reperfusion in the post-ischemic/reperfused zone to be significant at 24 hours (Table 2 , Fig 5) . The calculated fraction of endothelial surface P-selectin [(P-selectin -GPIIb/IIIa)/ CD31] was consistently and significantly elevated in the post-ischemic/reperfused zone at all time points up to 24 hours (5.5% to 9.5% of CD31) ( Table 2, Fig 6) .
A simple assessment of the intensity of microvesselassociated peroxidase stain was made to further indicate the responses of P-selectin to ischemia/reperfusion. The intensity of P-selectin-associated stain in the area of the post-ischemic/reperfused zone with type IV neuron changes was generally greater (level 2) than that of the non-ischemic/reperfused zone and of the control subjects at all time points (Table 3) . Lighter stained microvessels (level 1) were found scattered in the peripheral area.
To further estimate the distribution of total microvascular endothelial P-selectin, sections were fixed with acetone, which served to increase endothelial cell permeability to the anti-P-selectin antibodies. 30 The proportion of total endothelial P-selectin (acetone) available as surface-expressed P-selectin (methanol) was significantly greater (/ ) <.O5) in the post-ischemic/ reperfused basal ganglia than in the nonischemic basal Figs  1 and 2 and text) . Center refers to region with type IV neuron damage; peripheral area had predominantly type II and III injury, without type IV.
*P-selectin is a polyclonal preparation; ICAM-1, monoclonal preparation. 'Note that in the non-l/R zone microvessels without stain (level 0) accounted for 98.6 ±1.1% of the total vessel number. ganglia during MCA occlusion and MCA occlusion/ reperfusion (Fig 7) . Moreover, microvascular P-selectin seen in acetone-fixed specimens occurred predominantly (78% to 95%) in the noncapillary vessels, in a distribution identical to that of surface-expressed P-selectin (Fig 3) . There was no significant difference in the number of P-selectin-containing microvessels between the non-ischemic/reperfused and post-ischemic/reperfused sides in the acetone-fixed specimens (data not shown).
The appearance of the PMN leukocyte CDllb/CD18 counterreceptor ICAM-1 was also studied. Anti-ICAM-1 MoAb was detected on the endothelium of affected microvessels (Fig 2) . In the post-ischemic/reperfused basal ganglia, the fraction of ICAM-1-positive microvessels increased significantly (P<.05) at 1 hour and 4 hours after reperfusion over the contralateral non-ischemic/reperfused basal ganglia and the control subjects ( Table 2 FIG 5. Bar graph shows mean fraction of microvessels with exposed P-selectin (black bars) and glycoprotein (GP) llb/llla (hatched bars). Specimens were methanol-fixed. P-selectin expression in the post-ischemia/reperfusion (I/R) zone was significantly increased at 2 hours of middle cerebral artery (MCA) occlusion (-1 hour reperfusion) and at 1 and 24 hours after reperfusion (P<.05). The fraction of GPIIb/llla-positive microvessels in the post-l/R zone was significantly greater than in the non-l/R zone at 24 hours of reperfusion (P<.05). C indicates control cohort. (See also Table 2 .) of ischemia. The frequency of ICAM-1 expression appeared maximal at 1 to 4 hours after reperfusion and gradually decreased with duration of reperfusion.
The intensity of endothelium-associated ICAM-1 signal in the post-ischemic/reperfused zone was no different than that of the few positive microvessels in the nonischemic/reperfused zone (Table 3) , although the number of positive vessels was significantly greater at 1 and 4 hours of reperfusion in the post-ischemic/reperfused zone (Fig  8) . ICAM-1 presented mainly in the noncapillary 7.5-to 30.0-^m-diameter microvessels (Fig 4) .
Discussion
There are few studies of P-selectin 73436 and ICAMl 37 -38 expression in vivo after focal ischemia/reperfusion and none so far in cerebral vessels during ischemia and reperfusion. The endothelial expression of P-selectin in microvessels of the LSA territory increased significantly in frequency after 2-hour MCA occlusion and then at 3-hour MCA occlusion/1-, 4-, and 24-hour reperfusion in the awake baboon, suggesting persistent upregulation FIG 7. Line graph shows mean fraction of P-selectin-positive microvessels after methanol (m) or acetone (a) fixation. The fraction of P-selectin-positive microvessels in the post-ischemia/ reperfusion (I/R) and non-l/R zones with methanol fixation (endothelial surface expression) represented up to 40% of those acetone-fixed microvessels (total endothelial cell P-selectin content). MCA indicates middle cerebral artery; C, control cohort. *P<.05.
of P-selectin after ischemia and reperfusion. In contrast, ICAM-1 expression appeared transiently at 1 and 4 hours after reperfusion in this model.
Here, the vascular distribution of P-selectin was primarily in the 7.5-to 30.0-^m-diameter group, consistent with the distribution of precapillary arterioles and postcapillary venules. The known preferential distribution of P-selectin and ICAM-1 expression in postcapillary venules is consistent with the favored site of ischemia/ reperfusion-related PMN leukocyte adhesion, 139 edema formation, 40 and granulocyte transmigration during inflammation.
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- 41 In this study, no P-selectin was seen in capillaries, which accords with the known absence of Weibel-Palade bodies and of P-selectin in capillary endothelium of other human tissues. 1041 Here, P-selectin was found on 9.6±3.1% and ICAM-1 on 10.0±6.8% of microvessels after 3-hour MCA occlusion/1-hour reperfusion ( Table 2 , Figs 6 and 8) . This complements the previous finding of PMN leukocytes in 3.7% of postcapillary microvessels (10.2±2.0 fim in diameter) early after ischemia/reperfusion. 1 P-selectin is constitutively synthesized in vessels of normal, noninflamed tissues but not expressed on the endothelial surface. 10 It was found in up to 38% of the microvessels in nonischemic LSA territory permeabilized with acetone (data not shown). In the present study, a mean of 1.4±1.0% of CD31-positive vessels in the nonischemic territory bound the anti-P-selectin or anti-ICAM-1 antibodies. These frequencies were regarded as the background number of positive microvessels for these studies. In frozen sections disruption of endothelial cells in vessels transected at a bias may expose intracellular P-selectin. It cannot be completely ruled out that the nonischemic tissue suffered some ischemia in processing, although the removal of cerebral tissues occurred rapidly. These factors may have contributed to the background of stained microvessels in the non-ischemic and control tissues. This number was small.
The agonists thrombin and histamine induce receptormediated fusion of Weibel-Palade bodies with the plasma membrane within seconds to minutes, leading to rapid redistribution of P-selectin to the endothelial cell sur- f ace 1012, 42 Sugama et al 43 demonstrated that a-thrombin challenge stimulated P-selectin expression on cultured human umbilical vein endothelial cells (HUVECs) within 15 minutes, which returned to basal levels within 60 to 90 minutes, presumably as a result of endocytosis.
1118 A direct relation between coagulation system activation and P-selectin surface expression is implied. 43 Findings of in vitro studies are consistent with the appearance of microvascular endothelial P-selectin by 2 hours of MCA occlusion and ischemia. 18 P-selectin in activated platelets contributed to the P-selectin signal observed predominantly at 4 and 24 hours of MCA reperfusion, as suggested by the intravascular distribution of platelet-associated GPIIb/IIIa. P-selectin remains on the surface of platelets for at least 1 hour after in vitro activation by thrombin. 44 Further, P-selectin expression on activated platelets may result from interaction with PMN leukocytes in postcapillary venules.
1 That P-selectin was confined to the endothelium during ischemia and early reperfusion is supported by its annular luminal appearance in positive microvessels and the relative absence of platelets at 1 hour of reperfusion. 1 The "sustained" appearance of P-selectin observed up to 24 hours after MCA occlusion/reperfusion is intriguing and may have several explanations. Continuous generation of thrombin by a number of mechanisms, including coagulation system activation, may contribute to endothelial and platelet P-selectin expression. The presence of a continuously generated stimulus (eg, thrombin) during cerebral ischemia and ischemia/reperfusion may promote a constant fraction of microvessels to display P-selectin, although not necessarily in the same microvessels. Low concentrations of oxygen free radicals induce sustained exposure of P-selectin on the endothelial cell surface over several hours. 45 Several cytokines, eg, TNF-a and IL-1, may upregulate endothelial P-selectin in vitro.
18 Although the precise mechanisms by which cerebral ischemia/reperfusion results in endothelial P-selectin expression are not yet clear, one ready explanation is the generation of thrombin within the ischemic microvasculature by exposure of tissue factor, the main initiator of the coagulation cascade to the plasma column. rectly to fibrin deposition through monocyte tissue factor. In vivo this unregulated expression of P-selectin could result in a vicious cycle of persistent neutrophil adhesion and activation, together with platelet activating factor release and platelet aggregation, tissue injury, cytokine release, further ICAM and P-selectin expression, and eventual tissue destruction.
ICAM-1 supports ischemia/reperfusion-induced granulocyte endothelial adhesion 46 and is necessary for transmigration. In this study, ICAM-1 was detected early after reperfusion (ie, 4 to 7 hours after the initiation of ischemia), after the appearance of P-selectin. Because mRNA synthesis is required, the initial appearance of ICAM-1 occurs 30 minutes after a-thrombin exposure 43 and may persist for up to 120 minutes in HUVECs. 43 Sobel et al 47 reported the presence of ICAM-1 antigen at 2 and 4 days in vessels of the infarct zone of two patients suffering stroke. Inflammatory stimuli including endotoxin, IL-1, and TNF-a lead to ICAM-1 expression.
1843 - 48 ' 49 In primary cultures of human brain microvessel endothelium, upregulation of ICAM-1 expression to continuous LPS or cytokine exposure was concentration and time dependent, appearing as early as 4 hours after incubation and persisting for up to 72 hours. 50 The transient appearance of ICAM-1, located on the endothelial cell surface, after MCA occlusion/reperfusion in this model implies that either the stimuli for expression (eg, cytokines) appear transiently or may be limited by reperfusion. Rapid postexpression metabolism of ICAM-1 may produce circulating products, which may be removed during reperfusion. 51 Alternatively, superoxide release from granulocytes trapped in the postcapillary venule during focal ischemia/reperfusion may stimulate ICAM-1 expression locally, and for a limited period in this model. 52 These observations raise the possibility that agents that block P-selectin and/or ICAM-1 function may attenuate edema formation and/or ischemic injury. Palabrica et al 7 noted that the anti-P-selectin MoAb GA6 could inhibit leukocyte-platelet binding and fibrin deposition in a baboon arteriovenous shunt. Another anti-P-selectin MoAb (PB1.3) significantly attenuated myocardial necrosis when administered 10 minutes before reperfusion in a feline myocardial ischemia/reperfusion model. 34 Harlan 35 reported that treatment with PB1.3 resulted in significantly less edema and tissue necrosis after 6-hour occlusion/reperfusion in a rabbit ear model.
Few in vivo studies of anti-ICAM-1 strategies on ischemia/reperfusion injury have been reported. 37 - 38 Ma et al 37 noted that cats exposed to the anti-ICAM-1 MoAb RR 1/1 developed significantly less myocardial necrosis and had enhanced endothelial-dependent relaxation to acetylcholine relative to those receiving nonbinding control antibody after myocardial ischemia/ reperfusion. In the central nervous system, Clark et al 38 found no improvement in the neurological deficit after anti-ICAM-1 MoAb R6.5 infusion in irreversible brain ischemia in a rabbit thromboembolism model. Neither study examined the appearance of ICAM-1 during ischemia/reperfusion.
After focal cerebral ischemia and reperfusion, cerebral microvascular endothelia display a prolonged expression of P-selectin and a transient appearance of ICAM-1 on their surface. In other systems, the coordinate appearance of both adhesion receptors is required for "rolling" of circulating granulocytes, their endothelial adhesion in postcapillary venules, transmigration, and eventual tissue destruction. The appearance of both adhesion receptors and PMN leukocyte adherence in postcapillary venules after MCA occlusion/reperfusion is consistent with those findings. 1 Such findings suggest that the effect of anti-P-selectin and of anti-ICAM-1 strategies on the microvascular consequences of focal cerebral ischemia and reperfusion should be carefully studied in appropriate models.
Editorial Comment
In this issue of Stroke, Okada and coworkers report that middle cerebral artery occlusion/reperfusion alters the surface expression of intercellular adhesion molecule-1 (ICAM-1) and P-selectin on microvessel endothelium in regions of the brain subjected to ischemia. The expression of these molecular determinants of leukocyte/endothelial cell adhesion was not detected on capillary endothelium but was noted in approximately 10% of microvessels with diameters ranging between 7.5 and 30 fim. Although the type of vessel expressing ICAM-1 and P-selectin was not characterized, the fact that leukocyte adhesion occurs preferentially in post-
